Navigation Links
Mayo Clinic discovers African-Americans respond better to rubella vaccine
Date:2/26/2014

ROCHESTER, Minn. Feb. 26, 2014 Somali Americans develop twice the antibody response to rubella from the current vaccine compared to Caucasians in a new Mayo Clinic study on individualized aspects of immune response. A non-Somali, African-American cohort ranked next in immune response, still significantly higher than Caucasians, and Hispanic Americans in the study were least responsive to the vaccine. The findings appear in the journal Vaccine.

"This is fascinating," says Gregory Poland, M.D., Mayo Clinic vaccinologist and senior author of the study. "We don't know why these groups reacted so differently to the vaccine that's a subject for further studies but this new information will help us as we design the vaccines of the future. It will ultimately change how we practice medicine."

The researchers studied a sample of 1,100 healthy children and young adults in Rochester, as well as over 1,000 participants from the U.S. Naval Health Research Center in San Diego as the control group. The Navy members, aged 18 to 40, were all healthy and recently vaccinated, and represented a cross-section of ethnic groups. The study also looked at a subset of a recent immigrant population from Somalia in Rochester. The Minnesota case studies were done in cooperation with the Rochester Epidemiology Project.

The researchers hypothesized that race, sex or ethnicity might contribute to differences in immune response. They found no difference in gendera surprise, says Dr. Poland, because in most studies women consistently have a better immune response to vaccines than men.

"The significance of the findings is that in the future we may be able to create vaccines for specific groups or even individuals based on their genomic and other characteristics," says Dr. Poland. "That may mean adjusting doses for some or being able to treat larger populations with the same vaccine if the dosage is less."


'/>"/>

Contact: Bob Nellis
newsbureau@mayo.edu
507-284-5005
Mayo Clinic
Source:Eurekalert

Page: 1

Related medicine news :

1. Clinical opinion published on use of maternal oxygen during labor
2. REACT clinical trial supports new approach of accelerated treatment for Crohns disease
3. Cell therapy shows remarkable ability to eradicate cancer in clinical study
4. Clinical trial success influenced by biomarker- and receptor-targeted therapies in NSCLC
5. Rare bacteria outbreak in cancer clinic tied to lapse in infection control procedure
6. Paper examines clinical and policy implications of intimate partner violence
7. Mayo Clinic identifies a key cellular pathway in prostate cancer
8. Analysis of calls to IBD clinic predicts emergency visits and hospitalizations, Pitt finds
9. $7 million multi-institutional contract creates New York City Clinical Data Research Network
10. Mayo Clinic study finds standardized protocol and surgery improve mortality outcomes
11. Cedars-Sinai clinical trial studies vaccine targeting cancer stem cells in brain cancers
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:1/16/2017)... New York (PRWEB) , ... January 16, 2017 ... ... SightMD today announced the addition of Victor Giamos, MD to their ... of SightMD and Managing Partner at North Shore Eye Care, a division of ...
(Date:1/16/2017)... , ... January 16, 2017 , ... ... availability of the newly updated International Audit Protocol Consortium (IAPC) EHS audit protocol ... protocols to understand the scope of their EHS regulatory obligations and rapidly collect, ...
(Date:1/16/2017)... ... ... St. Louisans are well-aware of the following facts at present:, ... be having no effect on keeping this particularly bad strain of the flu away , ... sneezing, or sniffling , These facts are well-known among the team at ...
(Date:1/16/2017)... Beverly Hills, CA (PRWEB) , ... January 16, ... ... published a manuscript in the Aesthetic Surgery Journal , the official journal ... study he conducted on lower eyelid retraction surgery. The procedure is designed to ...
(Date:1/16/2017)... ... January 16, 2017 , ... One thing common to all types ... to test for, as well. The money spent screening for and treating cancer in ... U.S. screen patients for cancer more than in any other country that has an ...
Breaking Medicine News(10 mins):
(Date:1/13/2017)... , January 13, 2017 This ... see how they have fared at yesterday,s closing bell: ... Biopharma Inc. (NASDAQ: GALE ), and ACADIA ... harness cellular and biomolecular processes to develop technologies and ... environmental footprint, feed the hungry, use less and cleaner ...
(Date:1/13/2017)... 2017 The 2016 election resulted in ... states voting in favor of legalizing cannabis for recreational use, ... in the U.S. In addition, the state of ... cannabis products sales. The ArcView Group has published an updated ... cannabis sales in the U.S. last year reached $6.7 billion, a ...
(Date:1/13/2017)... 2017   JDRF , the leading global ... pleased to announce that after more than a ... & Medicaid Services (CMS) has recognized continuous glucose ... use in making diabetes treatment decisions as durable ... eligible for coverage under Medicare. JDRF has been ...
Breaking Medicine Technology: